NCT04710381View on ClinicalTrials.gov

IMUNOR® Preparation in the Prevention of COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

June 2, 2021

Study Completion Date

June 2, 2021

Conditions
Covid19
Interventions
DRUG

IMUNOR

The intervention consists of the administration of IMUNOR as prevention against COVID-19 disease

Trial Locations (1)

70852

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT04710381 - IMUNOR® Preparation in the Prevention of COVID-19 | Biotech Hunter | Biotech Hunter